Preclinical safety profile of disitamab vedotin：a novel anti-HER2 antibody conjugated with MMAE

•The toxicities associated with Disitamab vedotin were well characterized. Disitamab vedotin was well tolerated in preclinical studies in cynomolgus monkeys, the highest non-severely toxic dose was 6 mg/kg in repeated dose toxicity studies.•Disitamab vedotin toxicities are hematology toxicity that r...

Ausführliche Beschreibung